Courtney Beers
Fortune : 18 018 $ au 31/05/2026
Fortune : 18 018 $ au 31/05/2026
Courtney Beers is currently an Independent Director at Sangamo Therapeutics, Inc. since 2022 and Chief Scientific Officer at Tizona Therapeutics, Inc. since 2019.
Formerly, Dr. Beers was Head of Cancer Immunotherapy at Cascadian Therapeutics LLC.
Dr. Beers earned a doctorate from the University of Washington.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2025 | 82 650 ( 0,02% ) | 18 018 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/12/2022 |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Directeur Technique/Scientifique/R&D | 01/01/2019 |
| Sociétés | Poste | Fin |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cascadian Therapeutics LLC
Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national